January 25, 2013 at 05:41 AM EST
Huapont Pharma and Yes Biotech to Partner on Psoriasis Ointment
Huapont Pharma said its wholly-owned subsidiary Chongqing Huapont Pharm Co., has signed a letter of intent to partner with Yes Biotech, a Canadian company, to develop the latter company’s innovative psoriasis/eczema treatment. Both companies have an interest in dermatology products, and Yes Biotech already markets a psoriasis salve. Terms of the agreement were not disclosed, but it seems Huapont will make an investment in Yes Biotech. More details.... Stock Symbol: (SHE: 002004) Share this with colleagues: // //  
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here